May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Topical application of BM–derived stem cells enhances the repair of corneal injuries.
Author Affiliations & Notes
  • A. Gallazzi
    Regenerative Med. and Technology, MGH and Harvard Medical School, Cny 5212, MA
    Department of Pediatric Oncohematology and Department of Biopatology, Bambino Gesu’ Pediatric Hospital, IRCCS and "Tor Vergata" University, Rome, Italy
  • E. Ghinelli
    Ophthalmology, Schepens Eye Research Institute and Harvard Medical School, Boston, MA
    Ophthalmology, Casa di cura Polispecialistica Dott. Pederzoli, Peschiera del Garda (VR), Italy
  • G. Carito
    Ophthalmology, Casa di cura Polispecialistica Dott. Pederzoli, Peschiera del Garda (VR), Italy
  • G. Isacchi
    Department of Pediatric Oncohematology and Department of Biopatology, Bambino Gesu’ Pediatric Hospital, IRCCS and "Tor Vergata" University, Rome, Italy
  • D.T. Scadden
    Regenerative Med. and Technology, MGH and Harvard Medical School, Cny 5212, MA
  • Footnotes
    Commercial Relationships  A. Gallazzi, None; E. Ghinelli, None; G. Carito, None; G. Isacchi, None; D.T. Scadden, None.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 1432. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. Gallazzi, E. Ghinelli, G. Carito, G. Isacchi, D.T. Scadden; Topical application of BM–derived stem cells enhances the repair of corneal injuries. . Invest. Ophthalmol. Vis. Sci. 2004;45(13):1432.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To investigate cellular therapy applications, considered nowadays as a new approach for the healing of tissue injuries. In the ophthalmic field the use of autologous cells in the treatment of several ocular diseases has involved, not always successfully, limbal stem cells therapy. This approach, however, involve surgery, hospitalization of the patience and a strict follow–up. We propose a new approach for the healing of corneal injuries using hematopoietic stem cells. Methods:Female mice were injuried in both the eyes under anesthesia with ethanol 20% for 90 secs and corneal epithelium was scraped. Hematopoietic Lineage negative cells were selected from whole bone marrow (BM) of male donors, suspended in PBS and applied topically in one eye only (experimental group) while the fellow eye was treated with PBS eye drops (control group). Animals were daily evaluated for corneal re–epithelization grading, transparency and other optical properties. Mice were sacrificed after 1, 2 and 3 weeks and the corneas dissected and processed to perform a DNA PCR for Y–chromosome. Each procedure was performed in triplicate. Results:At each time point, we observed in the experimental group a progressive enhancement of the corneal epithelium healing rate, moving progressively from the periphery to the center of the injury. The optical properties of the corneal tissue were used as signs of a physiological healing. On the contrary, the control group showed a slower healing rate, associated in some cases with partial loss of corneal transparency, scarring and abnormal optical properties. We demonstrated the presence of donor cells in the corneal epithelium, revealing the presence of male Y–chromosome DNA, and its absence in the control group. Conclusions: Our data suggest that hematopoietic stem cells are capable of enhancing the in vivo healing rate of injured corneas, and of integration in the corneal epithelium preserving the optical characteristics of this tissue.

Keywords: cornea: epithelium • regeneration • transplantation 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×